User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration

Primary tabs

download
  • Open access
  • PDF
  • 1.70 M
Gordon-Alonso, Monica [UCL] Hirsch, Thibault [UCL] Wildmann, Claude [UCL] van der Bruggen, Pierre [UCL]

The presence of T cells in tumors predicts overall survival for cancer patients. However, why most tumors are poorly infiltrated by T cells is barely understood. T-cell recruitment towards the tumor requires a chemokine gradient of the critical IFNγ-induced chemokines CXCL9/10/11. Here, we describe how tumors can abolish IFNγ-induced chemokines, thereby reducing T-cell attraction. This mechanism requires extracellular galectin-3, a lectin secreted by tumors. Galectins bind the glycans of glycoproteins and form lattices by oligomerization. We demonstrate that galectin-3 binds the glycans of the extracellular matrix and those decorating IFNγ. In mice bearing human tumors, galectin-3 reduces IFNγ diffusion through the tumor matrix. Galectin antagonists increase intratumoral IFNγ diffusion, CXCL9 gradient and tumor recruitment of adoptively transferred human CD8+ T cells specific for a tumor antigen. Transfer of T cells reduces tumor growth only if galectin antagonists are injected. Considering that most human cytokines are glycosylated, galectin secretion could be a general strategy for tumor immune evasion.Most tumours are poorly infiltrated by T cells. Here the authors show that galectin-3 secreted by tumours binds both glycosylated IFNγ and glycoproteins of the tumour extracellular matrix, thus avoiding IFNγ diffusion and the formation of an IFNγ-induced chemokine gradient required for T cell infiltration.

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès libre
Publication date 2017
Language Anglais
Journal information "Nature Communications" - Vol. 8, p. 793 (2017)
Peer reviewed yes
Publisher Nature Publishing Group (London)
issn 2041-1723
e-issn 2041-1723
Publication status Publié
Affiliation UCL - SSS/DDUV - Institut de Duve
Links
  1. Munn David H, Bronte Vincenzo, Immune suppressive mechanisms in the tumor microenvironment, 10.1016/j.coi.2015.10.009
  2. Galon J., Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome, 10.1126/science.1129139
  3. Mahmoud Sahar M.A., Paish Emma Claire, Powe Desmond G., Macmillan R. Douglas, Grainge Matthew J., Lee Andrew H.S., Ellis Ian O., Green Andrew R., Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer, 10.1200/jco.2010.30.5037
  4. Molon Barbara, Ugel Stefano, Del Pozzo Federica, Soldani Cristiana, Zilio Serena, Avella Debora, De Palma Antonella, Mauri PierLuigi, Monegal Ana, Rescigno Maria, Savino Benedetta, Colombo Piergiuseppe, Jonjic Nives, Pecanic Sanja, Lazzarato Loretta, Fruttero Roberta, Gasco Alberto, Bronte Vincenzo, Viola Antonella, Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells, 10.1084/jem.20101956
  5. Salmon Hélène, Franciszkiewicz Katarzyna, Damotte Diane, Dieu-Nosjean Marie-Caroline, Validire Pierre, Trautmann Alain, Mami-Chouaib Fathia, Donnadieu Emmanuel, Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors, 10.1172/jci45817
  6. Lesokhin A. M., Hohl T. M., Kitano S., Cortez C., Hirschhorn-Cymerman D., Avogadri F., Rizzuto G. A., Lazarus J. J., Pamer E. G., Houghton A. N., Merghoub T., Wolchok J. D., Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor Microenvironment, 10.1158/0008-5472.can-11-1792
  7. Spranger Stefani, Bao Riyue, Gajewski Thomas F., Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity, 10.1038/nature14404
  8. Harlin H., Meng Y., Peterson A. C., Zha Y., Tretiakova M., Slingluff C., McKee M., Gajewski T. F., Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment, 10.1158/0008-5472.can-08-2281
  9. Mlecnik Bernhard, Tosolini Marie, Charoentong Pornpimol, Kirilovsky Amos, Bindea Gabriela, Berger Anne, Camus Matthieu, Gillard Mélanie, Bruneval Patrick, Fridman Wolf–Herman, Pagès Franck, Trajanoski Zlatko, Galon Jérôme, Biomolecular Network Reconstruction Identifies T-Cell Homing Factors Associated With Survival in Colorectal Cancer, 10.1053/j.gastro.2009.10.057
  10. Romagnani Paola, Lasagni Laura, Annunziato Francesco, Serio Mario, Romagnani Sergio, CXC chemokines: the regulatory link between inflammation and angiogenesis, 10.1016/j.it.2004.02.006
  11. Groom Joanna R, Luster Andrew D, CXCR3 ligands: redundant, collaborative and antagonistic functions, 10.1038/icb.2010.158
  12. Guirnalda Patrick, Wood Laurence, Goenka Radhika, Crespo Joel, Paterson Yvonne, Interferon γ-induced intratumoral expression of CXCL9 alters the local distribution of T cells following immunotherapy withListeria monocytogenes, 10.4161/onci.25752
  13. Nakajima, C. et al. A role of interferon-gamma (IFN-gamma) in tumor immunity: T cells with the capacity to reject tumor cells are generated but fail to migrate to tumor sites in IFN-gamma-deficient mice. Cancer Res. 61, 3399–3405 (2001).
  14. Peng W., Liu C., Xu C., Lou Y., Chen J., Yang Y., Yagita H., Overwijk W. W., Lizee G., Radvanyi L., Hwu P., PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN-  Inducible Chemokines, 10.1158/0008-5472.can-12-1187
  15. Barreira da Silva Rosa, Laird Melissa E, Yatim Nader, Fiette Laurence, Ingersoll Molly A, Albert Matthew L, Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy, 10.1038/ni.3201
  16. Peng Dongjun, Kryczek Ilona, Nagarsheth Nisha, Zhao Lili, Wei Shuang, Wang Weimin, Sun Yuqing, Zhao Ende, Vatan Linda, Szeliga Wojciech, Kotarski Jan, Tarkowski Rafał, Dou Yali, Cho Kathleen, Hensley-Alford Sharon, Munkarah Adnan, Liu Rebecca, Zou Weiping, Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy, 10.1038/nature15520
  17. Gajewski Thomas F., Meng Yuru, Blank Christian, Brown Ian, Kacha Aalok, Kline Justin, Harlin Helena, Immune resistance orchestrated by the tumor microenvironment, 10.1111/j.1600-065x.2006.00442.x
  18. G. Gritsenko Pavlo, Ilina Olga, Friedl Peter, Interstitial guidance of cancer invasion, 10.1002/path.3031
  19. Schedin P., Keely P. J., Mammary Gland ECM Remodeling, Stiffness, and Mechanosignaling in Normal Development and Tumor Progression, 10.1101/cshperspect.a003228
  20. Stowell Sean R., Ju Tongzhong, Cummings Richard D., Protein Glycosylation in Cancer, 10.1146/annurev-pathol-012414-040438
  21. Häuselmann Irina, Borsig Lubor, Altered Tumor-Cell Glycosylation Promotes Metastasis, 10.3389/fonc.2014.00028
  22. Rabinovich Gabriel A, Toscano Marta A, Jackson Shawn S, Vasta Gerardo R, Functions of cell surface galectin-glycoprotein lattices, 10.1016/j.sbi.2007.09.002
  23. Ohtsubo Kazuaki, Marth Jamey D., Glycosylation in Cellular Mechanisms of Health and Disease, 10.1016/j.cell.2006.08.019
  24. Cardoso Ana Carolina Ferreira, Andrade Luciana Nogueira de Sousa, Bustos Silvina Odete, Chammas Roger, Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments, 10.3389/fonc.2016.00127
  25. Gordon-Alonso Monica, Demotte Nathalie, van der Bruggen Pierre, Sugars boost exhausted tumor-infiltrating lymphocytes by counteracting immunosuppressive activities of galectins, 10.4161/onci.28783
  26. Nangia-Makker Pratima, Balan Vitaly, Raz Avraham, Regulation of Tumor Progression by Extracellular Galectin-3, 10.1007/s12307-008-0003-6
  27. Markowska Anna I., Jefferies Kevin C., Panjwani Noorjahan, Galectin-3 Protein Modulates Cell Surface Expression and Activation of Vascular Endothelial Growth Factor Receptor 2 in Human Endothelial Cells, 10.1074/jbc.m111.226423
  28. Demotte Nathalie, Stroobant Vincent, Courtoy Pierre J., Van Der Smissen Patrick, Colau Didier, Luescher Immanuel F., Hivroz Claire, Nicaise Julie, Squifflet Jean-Luc, Mourad Michel, Godelaine Danièle, Boon Thierry, van der Bruggen Pierre, Restoring the Association of the T Cell Receptor with CD8 Reverses Anergy in Human Tumor-Infiltrating Lymphocytes, 10.1016/j.immuni.2008.01.011
  29. Demotte N., Wieers G., Van Der Smissen P., Moser M., Schmidt C., Thielemans K., Squifflet J.-L., Weynand B., Carrasco J., Lurquin C., Courtoy P. J., van der Bruggen P., A Galectin-3 Ligand Corrects the Impaired Function of Human CD4 and CD8 Tumor-Infiltrating Lymphocytes and Favors Tumor Rejection in Mice, 10.1158/0008-5472.can-10-0761
  30. Petit Anne-Elisabeth, Demotte Nathalie, Scheid Benoît, Wildmann Claude, Bigirimana René, Gordon-Alonso Monica, Carrasco Javier, Valitutti Salvatore, Godelaine Danièle, van der Bruggen Pierre, A major secretory defect of tumour-infiltrating T lymphocytes due to galectin impairing LFA-1-mediated synapse completion, 10.1038/ncomms12242
  31. Wang Wei, Guo Huaijian, Geng Jianlin, Zheng Xiaodong, Wei Haiming, Sun Rui, Tian Zhigang, Tumor-released Galectin-3, a Soluble Inhibitory Ligand of Human NKp30, Plays an Important Role in Tumor Escape from NK Cell Attack, 10.1074/jbc.m114.603464
  32. Kouo T., Huang L., Pucsek A. B., Cao M., Solt S., Armstrong T., Jaffee E., Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells, 10.1158/2326-6066.cir-14-0150
  33. Chen I-Ju, Chen Hung-Lin, Demetriou Michael, Lateral Compartmentalization of T Cell ReceptorVersusCD45 by Galectin-N-Glycan Binding and Microfilaments Coordinate Basal and Activation Signaling, 10.1074/jbc.m706923200
  34. de Jager W., Hoppenreijs E. P A H, Wulffraat N. M, Wedderburn L. R, Kuis W., Prakken B. J, Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study, 10.1136/ard.2006.061853
  35. Barboni Erminia A.M., Bawumia Sulemana, Hughes R. Colin, 10.1023/a:1007004330048
  36. He Jiale, Baum Linda G., Galectin Interactions with Extracellular Matrix and Effects on Cellular Function, Methods in Enzymology (2006) ISBN:9780121828226 p.247-256, 10.1016/s0076-6879(06)17017-2
  37. Salomonsson Emma, Carlsson Michael C., Osla Veronica, Hendus-Altenburger Ruth, Kahl-Knutson Barbro, Öberg Christopher T., Sundin Anders, Nilsson Rickard, Nordberg-Karlsson Eva, Nilsson Ulf J., Karlsson Anna, Rini James M., Leffler Hakon, Mutational Tuning of Galectin-3 Specificity and Biological Function, 10.1074/jbc.m109.098160
  38. Fidler, I. J., Fogler, W. E., Kleinerman, E. S. & Saiki, I. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes. J. Immunol. 135, 4289–4296 (1985).
  39. Tan, K. W. et al. Tumor stroma and chemokines control T-cell migration into melanoma following Temozolomide treatment. Oncoimmunology 4, e978709 (2015).
  40. Starr R., Fuchsberger M., Lau L. S., Uldrich A. P., Goradia A., Willson T. A., Verhagen A. M., Alexander W. S., Smyth M. J., SOCS-1 Binding to Tyrosine 441 of IFN-  Receptor Subunit 1 Contributes to the Attenuation of IFN-  Signaling In Vivo, 10.4049/jimmunol.0901010
  41. Baurain J.-F., Colau D., van Baren N., Landry C., Martelange V., Vikkula M., Boon T., Coulie P. G., High Frequency of Autologous Anti-Melanoma CTL Directed Against an Antigen Generated by a Point Mutation in a New Helicase Gene, 10.4049/jimmunol.164.11.6057
  42. Cambien B, Karimdjee B F, Richard-Fiardo P, Bziouech H, Barthel R, Millet M A, Martini V, Birnbaum D, Scoazec J Y, Abello J, Saati T Al, Johnson M G, Sullivan T J, Medina J C, Collins T L, Schmid-Alliana A, Schmid-Antomarchi H, Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism, 10.1038/sj.bjc.6605078
  43. Chen Jun, Vistica Barbara P., Takase Hiroshi, Ham Don II, Fariss Robert N., Wawrousek Eric F., Chan Chi-Chao, DeMartino Julie A., Farber Joshua M., Gery Igal, A unique pattern of up- and down-regulation of chemokine receptor CXCR3 on inflammation-inducing Th1 cells, 10.1002/eji.200425318
  44. Gros Alena, Robbins Paul F., Yao Xin, Li Yong F., Turcotte Simon, Tran Eric, Wunderlich John R., Mixon Arnold, Farid Shawn, Dudley Mark E., Hanada Ken-ichi, Almeida Jorge R., Darko Sam, Douek Daniel C., Yang James C., Rosenberg Steven A., PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors, 10.1172/jci73639
  45. Ye Q., Song D.-G., Poussin M., Yamamoto T., Best A., Li C., Coukos G., Powell D. J., CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor, 10.1158/1078-0432.ccr-13-0945
  46. Opdenakker, G., Rudd, P. M., Wormald, M., Dwek, R. A. & Van Damme, J. Cells regulate the activities of cytokines by glycosylation. FASEB J. 9, 453–457 (1995).
  47. Lu Pengfei, Weaver Valerie M., Werb Zena, The extracellular matrix: A dynamic niche in cancer progression, 10.1083/jcb.201102147
  48. Henderson Neil C., Sethi Tariq, The regulation of inflammation by galectin-3, 10.1111/j.1600-065x.2009.00794.x
  49. Braeuer R. R., Zigler M., Kamiya T., Dobroff A. S., Huang L., Choi W., McConkey D. J., Shoshan E., Mobley A. K., Song R., Raz A., Bar-Eli M., Galectin-3 Contributes to Melanoma Growth and Metastasis via Regulation of NFAT1 and Autotaxin, 10.1158/0008-5472.can-12-2424
  50. Nangia-Makker P., Hogan V., Honjo Y., Baccarini S., Tait L., Bresalier R., Raz A., Inhibition of Human Cancer Cell Growth and Metastasis in Nude Mice by Oral Intake of Modified Citrus Pectin, 10.1093/jnci/94.24.1854
  51. Radosavljevic Gordana, Jovanovic Ivan, Majstorovic Ivana, Mitrovic Maja, Lisnic Vanda Juranic, Arsenijevic Nebojsa, Jonjic Stipan, Lukic Miodrag L., Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity, 10.1007/s10585-011-9383-y
  52. Leffler, H. & Nilsson, U. J. in Galectins and Disease Implications for Targeted Therapeutics Vol. 115 (eds Peter G. Traber & Anatole A. Klyosov) Ch. 2, 47–59 (2012).
  53. Blouin Cédric M., Hamon Yannick, Gonnord Pauline, Boularan Cédric, Kagan Jérémy, Viaris de Lesegno Christine, Ruez Richard, Mailfert Sébastien, Bertaux Nicolas, Loew Damarys, Wunder Christian, Johannes Ludger, Vogt Guillaume, Contreras Francesc-Xabier, Marguet Didier, Casanova Jean-Laurent, Galès Céline, He Hai-Tao, Lamaze Christophe, Glycosylation-Dependent IFN-γR Partitioning in Lipid and Actin Nanodomains Is Critical for JAK Activation, 10.1016/j.cell.2016.07.003
  54. Gao Xiaoge, Balan Vitaly, Tai Guihua, Raz Avraham, Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathway, 10.18632/oncotarget.1786
  55. Gajewski Thomas F., Louahed Jamila, Brichard Vincent G., Gene Signature in Melanoma Associated With Clinical Activity : A Potential Clue to Unlock Cancer Immunotherapy, 10.1097/ppo.0b013e3181eacbd8
Bibliographic reference Gordon-Alonso, Monica ; Hirsch, Thibault ; Wildmann, Claude ; van der Bruggen, Pierre. Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration. In: Nature Communications, Vol. 8, p. 793 (2017)
Permanent URL http://hdl.handle.net/2078.1/194484